Company PlaceholderGlobal PharmatechGBLP info
$0.35info0.00%24h
Global rank
Market cap$0
Change 7d0.00%
YTD Performance45.83%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Business data

    Global Pharmatech (GBLP) Stock Overview

    Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.

    GBLP Stock Information

    Symbol
    GBLP
    Address
    509 Maoxiang StreetChangchun, 130 012China
    Founded
    -
    Trading hours
    -
    Website
    Country
    🇨🇳 China
    Phone Number
    86 431 8554 1826

    Global Pharmatech (GBLP) Price Chart

    -
    Value:-

    Global Pharmatech Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.35
    N/A
    Market Cap
    $0
    N/A
    Shares Outstanding
    0
    N/A
    Employees
    217.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org